Major component of cyclic peptide antibiotic complex also containing minor component Berninamycin B ( C51H51N15O14S ). Isoln from Streptomyces bernesis Dietz: M. E. Bergy et al., US 3689639 (1972). Inhibition of protein synthesis: F. Reusser, Biochemistry 8, 3303 (1969); J. Thompson et al., J. Gen. Microbiol. 128, 875 (1982). Structural studies and characterization of degradation product berninamycinic acid, a novel sulfur containing moiety: J. M. Liesch et al., J. Am. Chem. Soc. 98, 299 (1976); J. M. Liesch et al., ibid. 8237; J. M. Liesch, K. L. Rinehart, Jr., ibid. 99, 1645 (1977). Revised structure: H. Abe et al., Tetrahedron Lett. 29, 1401 (1988). Confirmation of structures: R. C. M. Lau, K. L. Rinehart, J. Antibiot. 47, 1466 (1994). Biosynthetic study: C. J. Pearce, K. L. Rinehart, Jr., J. Am. Chem. Soc. 101, 5069 (1979). Use as growth permittant: R. M. Pellegrino, EP 112233 (1984 to Merck & Co.). Synthesis of berninamycinic acid: T. R. Kelly et al., Tetrahedron Lett. 25, 2127 (1984).